<div id="readability-page-1"><p>Exchange Traded Concepts LLC grew its holdings in  CVS Health Corporation (NYSE:CVS - Free Report) by 86.7% in the third quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 34,298 shares of the pharmacy operator's stock after buying an additional 15,927 shares during the period. Exchange Traded Concepts LLC's holdings in CVS Health were worth $2,586,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li></ul><p>A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank purchased a new position in  CVS Health in the 2nd quarter worth approximately $1,358,698,000.  Invesco Ltd. increased its holdings in shares of  CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator's stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter.  Robeco Institutional Asset Management B.V. lifted its position in  CVS Health by 815.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator's stock worth $183,701,000 after buying an additional 2,372,121 shares in the last quarter.  Kingstone Capital Partners Texas LLC acquired a new position in  CVS Health during the second quarter worth $155,185,000.  Finally, Jennison Associates LLC grew its holdings in  CVS Health by 111.7% in the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator's stock valued at $276,895,000 after buying an additional 2,117,798 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Analyst Ratings Changes</h2><p>Several research analysts have recently weighed in on the stock. Wolfe Research boosted their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an &#34;outperform&#34; rating in a research report on Monday, December 8th. Weiss Ratings  reiterated a &#34;hold (c-)&#34; rating on shares of CVS Health in a report on Monday. JPMorgan Chase &amp; Co. raised their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, December 17th. Evercore ISI upped their price objective on CVS Health from $85.00 to $95.00 and gave the company an &#34;outperform&#34; rating in a report on Thursday, October 30th. Finally, Cantor Fitzgerald  reiterated an &#34;overweight&#34; rating on shares of CVS Health in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned  a Buy rating and four have assigned  a Hold rating to the company's stock. According to MarketBeat, the company  has an average rating of &#34;Moderate Buy&#34; and an average target price of $94.67.</p><ul><li>MarketBeat Week in Review – 05/12 - 05/16</li></ul><p><b>Check Out Our Latest Analysis on CVS</b></p><h2>CVS Health Stock Performance</h2><p>Shares of CVS stock opened at $79.06 on Friday. CVS Health Corporation has a one year low of $43.65 and a one year high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm's 50 day moving average price is $78.97 and its 200-day moving average price is $72.79. The firm has a market cap of $100.35 billion, a P/E ratio of 208.04, a P/E/G ratio of 0.78 and a beta of 0.48. </p><ul><li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li></ul><p>CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the company earned $1.09 earnings per share. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS.  As a group, equities research analysts predict that  CVS Health Corporation will post 5.89 EPS for the current year. </p><h2>CVS Health Profile</h2> (Free Report)<p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.  </p><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than CVS Health</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li><li>Washington prepares for war</li><li>Strange Crystal Metal Outperforms Silicon Up to 100X</li><li>33,000% boom from weird new “AI Fuel?”</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in CVS Health Right Now?</h2><p>Before you consider CVS Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Exchange Traded Concepts LLC increased its holdings in CVS Health Corporation by 86.7% in Q3, now owning 34,298 shares valued at $2.59 million. Other institutional investors also adjusted their positions. Analysts have given CVS Health a "Moderate Buy" rating with a target price of $94.67. CVS reported Q3 earnings of $1.60 per share, beating estimates, with revenue up 7.8% year-over-year. The company operates a large network of retail pharmacies and healthcare services.</p>

Exchange Traded Concepts LLC Grows Position in CVS Health Corporation $CVS